X

Oncology Times - Latest Articles

Oncology Times - Latest Articles
Final Results From the International Tailored Chemotherapy Adjuvant Trial

Findings from a Phase III study found that evaluating mRNA expression of selected genes to tailor adjuvant chemotherapy did not improve survival outcomes among patients with resected stage II-III N

Oncology Times - Latest Articles
04/01/2021
CARs Are the Ride of the Future for Curing DLBCL

Chimeric antigen receptor T-cell therapy has the potential to cure the most diffuse large B-cell lymphoma patients who have recurrent disease.

Oncology Times - Latest Articles
04/05/2021
CARs Are the Ride of the Future for Curing DLBCL

CAR T-cell therapy has the potential to cure the most diffuse large B-cell lymphoma patients who have recurrent disease.

Oncology Times - Latest Articles
04/05/2021
Relugolix As First Oral GnRH Antagonist Option for Prostate Cancer

The FDA recently approved relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, for adults with advanced prostate cancer. 

Oncology Times - Latest Articles
04/05/2021
NCCN Issues Guidance on COVID-19 Vaccination for Patients With Cancer

Oncology groups including ASCO, ASH, and the American Society for Radiation Oncology have all recommended patients with cancer get vaccinated. Now the NCCN has published a similar guidance.

Oncology Times - Latest Articles
04/05/2021
New Database of HPV-Negative Head & Neck Carcinomas Unveiled

New research clarifies the contributions of genes, proteins, and signaling pathways associated with HPV-negative head and neck squamous cell carcinomas.

Oncology Times - Latest Articles
04/05/2021
Significance of EZH2 Expression in Endometrial Cancer

To identify new targets, researchers have explored the relevance of epigenetic modifiers in cancer therapeutics. One such potential candidate is enhancer of zeste homolog 2 (EZH2). 

Oncology Times - Latest Articles
04/05/2021
Standardization & Harmonization of Immuno-Oncology Toxicities

A report from the Association of Community Cancer Centers shows that IO treatment is increasingly being given to patients in community settings, not just in academic cancer centers.

Oncology Times - Latest Articles
04/05/2021
Study Highlights Need to Protect Multiple Myeloma Patients From Infection

While there have been significant advancements in multiple myeloma treatment, infections—particularly bacterial and viral—remain major causes of morbidity and mortality among these patients...

Oncology Times - Latest Articles
03/20/2021
Multiple Myeloma: MMRF CureCloud Study Updates

The registry is designed to be the most comprehensive database of clinical and genomic information from thousands of patients with MM in the first at-home genomic testing program.

Oncology Times - Latest Articles
Subscribe to Oncology Times - Latest Articles

source list reference

#7d60d9
#2694a4
#32a887
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#03cffc
#42fc9a
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
#e7f6e3
#9a8c2c
#a9c507
#2b9ab3
#e61923
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#575662
#a60538
#49cde9
#c20fce
#d95d39